Results

Total Results: 921 records

Showing results for "morphine".

281. FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam). | PSNet
     psnet.ahrq.gov/issue/fda-cautions-about-dose-confusion-and-medication-errors-antibacterial-drug-zerbaxa
     April 08, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

282. FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change. | PSNet
     psnet.ahrq.gov/issue/fda-preliminary-public-health-notification-unpredictable-events-medical-equipment-due-new
     June 02, 2021 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

283. Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. | PSNet
     psnet.ahrq.gov/issue/differences-strength-expression-product-labels-compounders-and-conventional-manufacturers-may
     April 08, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

284. FDA MedWatch and Patient Safety Tutorial. | PSNet
     psnet.ahrq.gov/issue/fda-medwatch-and-patient-safety-tutorial
     April 08, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

285. Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens. | PSNet
     psnet.ahrq.gov/issue/information-healthcare-professionals-risk-transmission-blood-borne-pathogens-shared-use
     April 08, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

286. FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor). | PSNet
     psnet.ahrq.gov/issue/fda-drug-safety-communication-fda-warns-about-prescribing-and-dispensing-errors-resulting
     August 05, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

287. Teaching Kids About Using Medicine Safely. | PSNet
     psnet.ahrq.gov/issue/teaching-kids-about-using-medicine-safely
     April 08, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

288. Public Health Notification from FDA: Vail Products Enclosed Bed Systems. | PSNet
     psnet.ahrq.gov/issue/public-health-notification-fda-vail-products-enclosed-bed-systems
     December 16, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

289. Human Factors and Medical Devices. | PSNet
     psnet.ahrq.gov/issue/human-factors-and-medical-devices
     June 02, 2021 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

290. Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11. | PSNet
     psnet.ahrq.gov/issue/cardinal-health-recalls-argyle-uvc-insertion-tray-due-missing-instructions-use-safety-scalpel
     August 20, 2021 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

291. Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. | PSNet
     psnet.ahrq.gov/issue/potential-medication-overdose-enfit-low-dose-tip-syringe-fda-safety-communication
     October 28, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

292. FDA Funding Available for Research Aimed at Reducing Preventable Harm from Medication | PSNet
     psnet.ahrq.gov/issue/fda-funding-available-research-aimed-reducing-preventable-harm-medication
     October 20, 2021 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

293. OpenFDA. | PSNet
     psnet.ahrq.gov/issue/openfda
     April 08, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

294. FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved. | PSNet
     psnet.ahrq.gov/issue/fda-drug-safety-communication-fda-cautions-about-dosing-errors-when-switching-between
     April 08, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

295. Questions and Answers on FDA's Adverse Event Reporting System (FAERS). | PSNet
     psnet.ahrq.gov/issue/questions-and-answers-fdas-adverse-event-reporting-system-faers
     January 13, 2021 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

296. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. | PSNet
     psnet.ahrq.gov/issue/medwatch
     April 08, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

297. Use purple bracelets or wristbands only for do not resuscitate status - letter to industry. | PSNet
     psnet.ahrq.gov/issue/use-purple-bracelets-or-wristbands-only-do-not-resuscitate-status-letter-industry
     September 01, 2021 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

298. Be an Active Member of Your Health Care Team. | PSNet
     psnet.ahrq.gov/issue/be-active-member-your-health-care-team
     April 08, 2020 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

299. CHIPRA 218: Section 5, Table 6 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-218-section-5-table-6.pdf
     January 01, 2009 - For severe pain, parenteral opioids (e.g., morphine) are administered, usually with around‐the‐clock

300. Quick Tips for Buying Medicines Over the Internet. | PSNet
     psnet.ahrq.gov/issue/buying-medicines-over-internet
     July 18, 2007 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication